Cut down on Salt
“If all of us reduce our salt intake by one-third, it is estimated that the health budget can be cut by 40 per cent,” - Dr.RC
Cystinosis Foundation, India
Cystinosis is a rare genetic, metabolic disorder caused by accumulation of amino acid cystine within the cells.
Acute Kidney Injury (AKI): Video Launch
Launch of Video on Acute Kidney Injury on World Kidney Day 2013 by Actor-Arvind Swamy
Launch of sugarbp.org website
Actor Kamal Haasan launches www.sugarbp.org website, which will provide information on detection and treatment of chronic kidney disease.
Salt Sathyagraha
A walkathon lead by Dr. Rajan Ravichandran was organised on 7th March 2010 at Marina beach, Chennai.
Wednesday 14 October 2020
Wednesday 27 May 2020
Indomethacin in Covid-19 - Scientific evidence to try the drug
Indomethacin is a time honoured drug used as an anti-inflammatory drug specially in arthritis. It has also been used to prevent cytokine release while using an anti-rejection drug OKT3 very successfully (1,2). It also has antiviral properties when tried in the lab. It has been effective in SARS infection in the lab to reduce the viral load and hasten recovery (3). The drug is effective against canine corona virus (4). Unlike other NSAIDS it does not affect the clotting system (5). On the contrary it prevents thrombosis in lungs in experiments with septicemia (6).The medicine has low side effect profile when used for short periods .It would be best in to give indomethacin 25 to 50 mg twice a day or according to the body weight for at least 5 days to prevent the cytokine storm in symptomatic patients with Covid-19. The drug should be used early to save lives. It can reduce hospitalisations and spread of the virus by hastening recovery. Considering the scientific evidence and the low side effect profile a trial with Indomethacin is
The proposal to try indomethacin was submitted to the ICMR ,health minister India, UK govt and US gov on 29th April 2020. The chief medical officer of UK Dr Chris Witty has forwarded the proposal to the Therapeutic Task Force where it is under triage .Although there has been no reply from US govt 60 patients have been started on indomethacin in New York with promising results and Dr Jonathan Leibowitz has expressed interest in conducting a multinational case studies.
It is essential that we waste no further time in using indomethacin which is possibly superior to hydroxychloroquine according to Dr Jonathan Leibowitz.
Sunday 19 April 2020
Saturday 11 April 2020
Monday 16 July 2018
New York city high salt warning goes into effect
Follow us on Facebook - https://www.facebook.com/Sapiens-Health-Foundation-396381037079778/
Follow us on Twitter - https://twitter.com/sapienshealth